Novartis discussing Roche stake sale, but not imminent -sources

LONDON/ZURICH, April 25 (Reuters) - Novartis is

discussing options with banks for selling its 13.5 billion Swiss

franc ($13.8 billion) stake in rival Roche, though a

sale is not imminent, according to two people familiar with the

situation.

Read more